BRCA1 LGR more frequently occurred in ovarian cancer (1.31%, 33/2526), followed by breast cancer (0.67%, 12/1788) and neuroendocrine cancer (0.66%, 1/152). This evidence concerns the gene BRCA1 and neuroendocrine carcinoma.